Magnolia Bark Compound May Be New Treatment Option For Drug-Resistant Epilepsy
- byDoctor News Daily Team
- 15 July, 2025
- 0 Comments
- 0 Mins
In patients with epilepsy normal neurological activity becomes disrupted, causing debilitating seizures. Researchers have found a potential new treatment for this disorder by turning to traditional Chinese medicine. Tests of extracts from plants used in these ancient remedies led the team to one compound, derived from a magnolia tree, that could quell drug-resistant seizures
The new research has been published in ACS Chemical Neuroscience.
Epilepsy is one of the most common neurological diseases worldwide, and the World Health Organization estimates that about 50 million people have the disorder. Medications are available, but they don't help everyone. Research suggests that about 70% of patients with epilepsy can control it well with medication, leaving many patients without effective treatment. But even when they work, the drugs can cause a range of side effects, from dizziness to mood disruptions. To look for new drug leads that could help even those patients who don't respond to conventional anti-seizure medications, Peter de Witte and colleagues set their sights on plants used in traditional Chinese medicine.
The team collected 14 plants used in traditional Chinese medicine anti-seizure remedies. They then tested the plants' extracts in two types of zebrafish with epileptic-like seizures, one of which could respond to conventional anti-seizure medications, whereas the other type could not. Only extracts from the bark of Magnolia Officinalis, a tree native to China, reduced seizure-like behaviour in both types of fish. In tests with mice, the researchers found that the magnolia bark's most potent anti-seizure compound, magnolol, reduced the rodents' otherwise drug-resistant seizures. It and similar compounds in magnolia bark could provide a starting point for the development of treatments for resistant epilepsy, according to the researchers.
For more details click on the link: https://doi.org/10.1021/acschemneuro.9b00610
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Silent Heart Attacks Pose Long-Term Health Risks f...
- 06 November, 2025
Long-Term Melatonin Use Associated to Increased He...
- 06 November, 2025
Can Whole-Fat Dairy Reduce Risk of Heart Disease?
- 06 November, 2025
BFUHS notifies on Round 6 BSc Nursing admissions,...
- 06 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!